HELPER AND CYTOTOXIC T-CELL RESPONSES OF HIV TYPE 1-INFECTED INDIVIDUALS TO SYNTHETIC PEPTIDES OF HIV TYPE-1 REV

被引:21
作者
BLAZEVIC, V [1 ]
RANKI, A [1 ]
KROHN, KJE [1 ]
机构
[1] UNIV OULU,DEPT DERMATOL,SF-90220 OULU,FINLAND
关键词
D O I
10.1089/aid.1995.11.1335
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In cell-mediated immunity T cells recognize peptide fragments of the antigenic protein in association with major histocompatibility complex (MHC) proteins. Synthetic 9- to 16-mer peptides have been widely used to identify the region(s) of a protein that act as T cell epitope. Here, we report antigenic peptides identified on HIV-I regulatory protein Rev. Four synthetic peptides (amino acids 9-23, 25-39, 33-48, and 41-56) were first shown to stimulate T helper (Th) cell proliferation in peripheral blood lymphocytes (PBLs) derived from HIV-seropositive (HIV+) individuals. The same peptides induced cytotoxic T lymphocyte (CTL) activities toward the autologous target cells incubated with the peptides. Both responses were specific to the HIV infection as HIV-seronegative (HIV-) control individuals showed no significant proliferative or cytotoxic activity. The proliferating cells were CD4(+) T cells, and CTL activity was mediated by CD8(+) human leukocyte antigen (HLA)-restricted T cells. The identification of peptides containing epitopes that can induce both Th and CTL responses to regulatory proteins of HIV-1 in infected individuals might be important for vaccine development against AIDS. Since early regulatory proteins of HIV are expressed by the infected cells before the initiation of the synthesis of structural proteins, a CTL response against these proteins could destroy the infected cells before the release of infectious virions.
引用
收藏
页码:1335 / 1342
页数:8
相关论文
共 37 条
[11]   HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE T-HELPER EPITOPES IDENTIFIED IN MICE AND HUMANS - CORRELATION WITH A CYTOTOXIC T-CELL EPITOPE [J].
DEGROOT, AS ;
CLERICI, M ;
HOSMALIN, A ;
HUGHES, SH ;
BARND, D ;
HENDRIX, CW ;
HOUGHTEN, R ;
SHEARER, GM ;
BERZOFSKY, JA .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) :1058-1065
[12]   ANTIBODIES AGAINST AIDS PROTEINS [J].
DEVASH, Y ;
REAGAN, K ;
WOOD, D ;
TURNER, J ;
PARRINGTON, M ;
KANG, CY .
NATURE, 1990, 345 (6276) :581-581
[13]   T-HELPER CELL EPITOPES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) NEF PROTEIN IN RATS AND CHIMPANZEES [J].
ESTAQUIER, J ;
BOUTILLON, C ;
AMEISEN, JC ;
GRASMASSE, H ;
LECOCOQ, JP ;
BARBIER, B ;
DIXSON, A ;
TARTAR, A ;
CAPRON, A ;
AURIAULT, C .
MOLECULAR IMMUNOLOGY, 1992, 29 (04) :489-499
[14]   CARBOXYL-TERMINAL AND CENTRAL REGIONS OF HUMAN IMMUNODEFICIENCY VIRUS-1 NEF RECOGNIZED BY CYTOTOXIC LYMPHOCYTES-T FROM LYMPHOID ORGANS - AN INVITRO LIMITING DILUTION ANALYSIS [J].
HADIDA, F ;
PARROT, A ;
KIENY, MP ;
SADATSOWTI, B ;
MAYAUD, C ;
DEBRE, P ;
AUTRAN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :53-60
[15]   EPITOPE MAPPING [J].
HORSFALL, AC ;
HAY, FC ;
SOLTYS, AJ ;
JONES, MG .
IMMUNOLOGY TODAY, 1991, 12 (07) :211-213
[16]   SYNTHETIC VACCINES - PEPTIDES OF FORTUNE [J].
JANEWAY, C .
NATURE, 1991, 353 (6347) :792-792
[17]  
JULIUS M, 1993, IMMUNOL TODAY, V14, P177
[18]   ERADICATION OF ADENOVIRUS E1-INDUCED TUMORS BY E1A-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T [J].
KAST, WM ;
OFFRINGA, R ;
PETERS, PJ ;
VOORDOUW, AC ;
MELOEN, RH ;
VANDEREB, AJ ;
MELIEF, CJM .
CELL, 1989, 59 (04) :603-614
[19]   TEMPORAL ASPECTS OF DNA AND RNA-SYNTHESIS DURING HUMAN IMMUNODEFICIENCY VIRUS-INFECTION - EVIDENCE FOR DIFFERENTIAL GENE-EXPRESSION [J].
KIM, SY ;
BYRN, R ;
GROOPMAN, J ;
BALTIMORE, D .
JOURNAL OF VIROLOGY, 1989, 63 (09) :3708-3713
[20]  
LAMHAMEDICHERRA.S, 1992, AIDS, V6, P1249